Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis

BACKGROUND: Resistance to apoptosis is a major problem in ovarian cancer and correlates with poor prognosis. Osteoprotegerin (OPG) is a secreted factor in malignant ascites and acts as a decoy receptor for receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-related apoptosis-inducin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Denis, Matte, Isabelle, Rancourt, Claudine, Piché, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507713/
https://www.ncbi.nlm.nih.gov/pubmed/23153223
http://dx.doi.org/10.1186/1757-2215-5-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507713/
https://www.ncbi.nlm.nih.gov/pubmed/23153223
http://dx.doi.org/10.1186/1757-2215-5-34

Ejemplares similares